Publications by authors named "Pierre Ferre"

Claim this Profile
P
PVRIG is Expressed on Stem-Like T Cells in Dendritic Cell-Rich Niches in Tumors and Its Blockade May Induce Immune Infiltration in Non-Inflamed Tumors.
Zoya Alteber, Gady Cojocaru, Roy Z Granit, Inbal Barbiro, Assaf Wool, Pierre Ferre

Cancer Immunol Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor Effects.
Assaf Menachem, Zoya Alteber, Gady Cojocaru, Tal Fridman Kfir, Dan Blat, Pierre Ferre

Cancer Immunol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.
Ana Antunes, Luis Alvarez-Vallina, Federico Bertoglio, Nicolas Bouquin, Stéphanie Cornen

MAbs· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma.
Pierre Boyé, Franck Floch, François Serres, Zacharie Segaoula, Juliette Hordeaux

Oncotarget· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis.
Aurélie Pétain, Dafang Zhong, Xiaoyan Chen, Zhang Li, Shao Zhimin

Cancer Chemother Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.
Yunpeng Yang, Jianhua Chang, Cheng Huang, Yiping Zhang, Jie Wang, Pierre Ferre

J Thorac Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
Lubka T Roumenina, Marie V Daugan, Rémi Noé, Florent Petitprez, Yann A Vano

Cancer Immunol Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials.
Antonin Schmitt, Laurent Nguyen, Grégoire Zorza, Pierre Ferré, Aurélie Pétain

Br J Clin Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma.
Guillemette Fouquet, Stéphanie Guidez, Valentine Richez, Anne-Marie Stoppa, Christophe Le Tourneau, Pierre Ferre

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
Sylvia Guetz, Amanda Tufman, Joachim von Pawel, Achim Rittmeyer, Astrid Borgmeier

Onco Targets Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.
Benoît Thibault, Emily Clement, Grégoire Zorza, Samuel Meignan, Jean-Pierre Delord

Cancer Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma.
Dominique Tierny, François Serres, Zacharie Segaoula, Ingrid Bemelmans, Emmanuel Bouchaert

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer.
Caroline Tournoux-Facon, Gilles Robinet, Marie-Claire Pinel, Pierre Ferre, Jean-Marc Tourani

Am J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trials.
Jean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, Joël Bougaret, Maud Brandely-Talbot

Clin Pharmacokinet· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphatico-venous bypass: surgical technique and aftercare in a porcine model.
Guillaume Chanoit, Pierre J Ferré, Hervé P Lefebvre

Interact Cardiovasc Thorac Surg· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury.
Pierre J Ferré, Laurence Liaubet, Didier Concordet, Magali SanCristobal, Emmanuelle Uro-Coste

Pharm Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU.
Pierre J Ferré, Kirby Pasloske, Ted Whittem, Millagahamanda G Ranasinghe, Qiang Li

Vet Anaesth Analg· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration.
Pierre Jean Ferré, Eckart Thein, Isabelle Raymond-Letron, Pierre-Louis Toutain, Hervé Pierre Lefebvre

Pharm Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis